Ubs Asset Management Americas Inc Arcellx, Inc. Transaction History
Ubs Asset Management Americas Inc
- $381 Billion
- Q3 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Arcellx, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 282,855 shares of ACLX stock, worth $24.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
282,855
Previous 310,382
8.87%
Holding current value
$24.8 Million
Previous $17.1 Million
37.9%
% of portfolio
0.01%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ACLX
# of Institutions
205Shares Held
44.2MCall Options Held
2.23MPut Options Held
907K-
Paradigm Biocapital Advisors LP New York, NY4MShares$351 Million12.04% of portfolio
-
Perceptive Advisors LLC New York, NY3.89MShares$342 Million8.48% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$329 Million23.89% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$309 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.46MShares$216 Million0.0% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $3.85B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...